JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M Turnover 14.14%
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
-8.19%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$572M
AUM Growth
-$51.6M
Cap. Flow
+$9.88M
Cap. Flow %
1.73%
Top 10 Hldgs %
35.91%
Holding
163
New
6
Increased
40
Reduced
67
Closed
6
Avg Time Held
3.7 years
Top 10 Avg Time Held
3.6 years
Top 20 Avg Time Held
3.4 years

Top Buys

Rank Stock Value
1
GNRC icon
Generac Holdings
GNRC
+$6.4M
2
JPM icon
JPMorgan Chase
JPM
+$3.46M
3
HRI icon
Herc Holdings
HRI
+$2.69M
4
TSM icon
TSMC
TSM
+$2.55M
5
WDC icon
Western Digital
WDC
+$2.39M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$5.13M
2
ELAN icon
Elanco Animal Health
ELAN
+$3.64M
3
GSK icon
GSK
GSK
+$2.52M
4
MNDT
Mandiant, Inc. Common Stock
MNDT
+$2.47M
5
XRAY icon
Dentsply Sirona
XRAY
+$2.24M

Sector Composition

Rank Sector Weight
1 Technology 24.19%
2 Healthcare 22.43%
3 Industrials 17.22%
4 Utilities 15.31%
5 Energy 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EMR icon
1
Emerson Electric
EMR
$89.9B
$28.5M 4.99%
389,468
+15,160
+4% +$1.26M
2013 Q2
37 quarters
BMY icon
2
Bristol-Myers Squibb
BMY
$121B
$27M 4.73%
380,235
-3,911
-1% -$284K
2013 Q2
37 quarters
PFE icon
3
Pfizer
PFE
$166B
$27M 4.72%
616,140
-6,500
-1% -$316K
2013 Q2
37 quarters
GLW icon
4
Corning
GLW
$121B
$22.4M 3.92%
772,933
+22,907
+3% +$776K
2013 Q2
37 quarters
OGE icon
5
OGE Energy
OGE
$9.81B
$22M 3.85%
603,975
-13,315
-2% -$537K
2013 Q2
37 quarters
XOM icon
6
ExxonMobil
XOM
$728B
$20M 3.5%
229,325
-1,444
-0.6% -$132K
2013 Q2
37 quarters
IBM icon
7
IBM
IBM
$215B
$15.8M 2.77%
133,120
-4,165
-3% -$547K
2013 Q2
37 quarters
CSCO icon
8
Cisco
CSCO
$448B
$15.7M 2.74%
391,666
+1,860
+0.5% +$82.5K
2013 Q2
37 quarters
NVS icon
9
Novartis
NVS
$279B
$15M 2.63%
197,894
+9,180
+5% +$761K
2013 Q2
37 quarters
TEL icon
10
TE Connectivity
TEL
$60.9B
$11.7M 2.05%
106,334
+6,725
+7% +$837K
2013 Q2
37 quarters
MRK icon
11
Merck
MRK
$364B
$11.5M 2.01%
133,472
-1,447
-1% -$129K
2013 Q2
37 quarters
SLB icon
12
SLB Ltd
SLB
$72B
$11.5M 2.01%
319,501
-1,353
-0.4% -$49.1K
2020 Q4
7 quarters
MDU icon
13
MDU Resources
MDU
$3.9B
$11.4M 1.99%
1,094,108
-26,462
-2% -$292K
2013 Q2
37 quarters
INTC icon
14
Intel
INTC
$519B
$11M 1.92%
425,599
+45,561
+12% +$1.55M
2013 Q2
37 quarters
BCE icon
15
BCE
BCE
$18.3B
$9.74M 1.7%
232,270
-3,550
-2% -$172K
2013 Q2
37 quarters
TSM icon
16
TSMC
TSM
$2.23T
$9.47M 1.66%
138,135
+30,835
+29% +$2.55M
2016 Q4
23 quarters
LNN icon
17
Lindsay Corp
LNN
$1.14B
$9.03M 1.58%
62,992
-188
-0.3% -$28.5K
2013 Q2
37 quarters
BKH icon
18
Black Hills Corp
BKH
$5.83B
$8.89M 1.56%
131,270
-1,680
-1% -$126K
2020 Q4
7 quarters
MSFT icon
19
Microsoft
MSFT
$3.96T
$8.64M 1.51%
37,104
-150
-0.4% -$39.6K
2013 Q2
37 quarters
D icon
20
Dominion Energy
D
$55.2B
$8.52M 1.49%
123,252
+2,120
+2% +$171K
2020 Q3
8 quarters
TMP icon
21
Tompkins Financial
TMP
$1.38B
$8.29M 1.45%
114,119
-1,170
-1% -$87.5K
2020 Q2
9 quarters
TMO icon
22
Thermo Fisher Scientific
TMO
$249B
$7.88M 1.38%
15,544
-2,000
-11% -$1.12M
2013 Q2
37 quarters
NJR icon
23
New Jersey Resources
NJR
$5.26B
$7.55M 1.32%
195,040
-4,000
-2% -$178K
2020 Q4
7 quarters
AGX icon
24
Argan
AGX
$5.13B
$7.45M 1.3%
231,590
-17,195
-7% -$606K
2018 Q2
17 quarters
LGTY
25
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$7.43M 1.3%
485,181
-6,630
-1% -$113K
2013 Q2
37 quarters

Similar funds

John G. Ullman & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, John G. Ullman & Associates held 163 positions worth $572M, down 8.3% from $623M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

John G. Ullman & Associates's Q3 2022 filing shows 6 new, 40 increased, 67 reduced and 6 closed positions. Its largest new stake was Herc Holdings: 24,171 shares worth $2.51M. The largest sale was 3M, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • John G. Ullman & Associates's largest Q3 2022 buy was Herc Holdings: 24,171 shares worth $2.51M.
  • John G. Ullman & Associates added most to Generac Holdings in Q3 2022, an estimated $6.4M increase.
  • John G. Ullman & Associates's biggest Q3 2022 reduction was GSK, cutting an estimated $2.52M.
  • John G. Ullman & Associates fully exited 3M in Q3 2022, selling an estimated $5.13M.
  • John G. Ullman & Associates's ten largest holdings make up 36% of its $572M portfolio in Q3 2022.
  • John G. Ullman & Associates opened 6 new positions and closed 6 in Q3 2022.
  • John G. Ullman & Associates's portfolio value fell 8.3% quarter-over-quarter to $572M.

Based on John G. Ullman & Associates's 13F filing for Q3 2022, filed 19 Oct 2022.